40611-79-8

Basic information

• Product Name: 1H-Pyrrole-2-carboxylicacid,4-formyl-,methylester(9CI)
• Synonyms: 1H-Pyrrole-2-carboxylicacid,4-formyl-,methylester(9CI);methyl 4-formyl-1H-pyrrole-2-carboxylate;4-Formylpyrrole-2-carboxylic acid methyl ester;2-Carbomethoxypyrrole-4-carboxaldehyde;1H-Pyrrole-2-carboxylic acid, 4-forMyl-, Methyl ester;4-ForMyl-1H-Pyrrole-2-carboxylicacidMethylester
• CAS NO: 40611-79-8
• Molecular Formula: C₇H₇NO₃
• Molecular Weight: 153.14
• Product Categories: CARBOXYLICESTER;Building Blocks;Pyrrole
• Mol File: 40611-79-8.mol
• Article Data: 19

Chemical Properties

• Melting Point: 124-125°
• Boiling Point: 328.458 °C at 760 mmHg
• Flash Point: 152.446 °C
• Appearance: /
• Density: 1.305 g/cm³
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 13.66±0.50(Predicted)
• CAS DataBase Reference: 1H-Pyrrole-2-carboxylicacid,4-formyl-,methylester(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrrole-2-carboxylicacid,4-formyl-,methylester(9CI)(40611-79-8)
• EPA Substance Registry System: 1H-Pyrrole-2-carboxylicacid,4-formyl-,methylester(9CI)(40611-79-8)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 40611-79-8(Hazardous Substances Data)

Usage

General Description

1H-Pyrrole-2-carboxylic acid, 4-formyl-, methyl ester (9CI) is a chemical compound with the molecular formula C8H7NO2. It is a methyl ester derivative of 1H-pyrrole-2-carboxylic acid, which is a heterocyclic compound containing a pyrrole ring. The 4-formyl group indicates the presence of an aldehyde functional group at the 4-position of the pyrrole ring. This chemical may have various applications in organic synthesis, pharmaceuticals, or as a building block for the synthesis of other compounds. It is important to handle this chemical with care and follow proper safety precautions, as it may have potential health hazards if mishandled.

Upstream product

• 1193-62-0 methyl Pyrrole-2-carboxylate 
• 65611-08-7 dichloromethyl propyl ether 
• 55314-16-4 (E)-3-(dimethylamino)-1-(pyridin-3-yl)prop-2-en-1-one 
• 68-12-2 N,N-dimethyl-formamide 
• 350-03-8 methyl-3-pyridylketone 
• 35302-72-8 pyrrol-2-yl trichloromethyl ketone 
• 542-88-1 bis(2-chloromethyl)ether 
• 3724-43-4 Vilsmeier reagent 
• 634-97-9 pyrrole-2-carboxyl acid 
• 4885-02-3 Dichloromethyl methyl ether 

Downstream Products

• 67858-48-4 5-(methoxycarbonyl)-1H-pyrrole-3-carboxylic acid 
• 1192686-22-8 methyl 4-formyl-1-(2-(3-methoxyphenyl)-2-oxoethyl)-1H-pyrrole-2-carboxylate 
• 1004752-92-4 methyl (2-bromo-5-(3-amino-4-(phenylethynyl)benzoyl)thiophen-3-yl)acetate 
• 1374326-54-1 benzyl 4-((2-amino-4-(5-bromo-4-(2-ethoxy-2-oxoethyl)thiophene-2-carbonyl)phenyl)ethynyl)benzoate 
• 1374326-78-9 ethyl (2-bromo-5-(3-amino-4-(phenylethynyl)benzoyl)-thiophen-3-yl)acetate 
• 1561964-86-0 methyl 4-(cyclohexyl(hydroxy)methyl)-1H-pyrrole-2-carboxylate 
• 1561964-88-2 methyl 4-(cyclohexylmethyl)-1H-pyrrole-2-carboxylate 
• 1561964-90-6 methyl 5-bromo-4-(cyclohexylmethyl)-1H-pyrrole-2-carboxylate 
• 1561964-93-9 methyl 5-(3-(tert-butyl)-5-(1-methylcyclopropyl)phenyl)-4-(cyclohexylmethyl)-1H-pyrrole-2-carboxylate 
• 1561964-95-1 5-(3-(tert-butyl)-5-(1-methylcyclopropyl)phenyl)-4-(cyclohexylmethyl)-1H-pyrrole-2-carboxylic acid 
• 1561958-56-2 5-(3-(tert-butyl)-5-(1-methylcyclopropyl)phenyl)-4-(cyclohexylmethyl)-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrrole-2-carboxamide 
• 1192683-10-5 N-(1-methylethyl)-2-[3-[3-(methyloxy)phenyl]-1-oxo-7-{[3-(1-piperidinyl)-propyl]oxy}pyrrolo[1,2-a]pyrazin-2(1H)-yl]acetamide 
• 1192686-28-4 methyl 1-(2-(3-methoxyphenyl)-2-oxoethyl)-4-(3-(piperidin-1-yl)propoxy)-1H-pyrrole-2-carboxylate 
• 1192686-31-9 3-(3-methoxyphenyl)-7-(3-(piperidin-1-yl)propoxy)pyrrolo[1,2-a]pyrazin-1(2H)-one 

Relevant articles and documents

Computer Modeling and Synthesis of Potential Inhibitors of Tyrosine Kinase BCR-ABL with the T315I Mutation

Abstract—: A comparative analysis of the interaction of the chimeric protein BCR-ABL, of the normal type and with the T315I mutation, with known inhibitors as well as compounds potentially capable of inhibiting the mutant protein has been carried out by computer modeling. It has been shown that the compounds proposed are incorported into the structure of the protein with the retention of the basic hydrogen bonds and intermolecular interactions. Two structures containing the pyrrole cycle have been synthesized, which, according to the results of computer modeling, appear to be most promising.

SPIRO-SUBSTITUTED OXINDOLE DERIVATIVES HAVING AMPK ACTIVITY

The present invention relates to compounds of formula (I), which have valuable pharmacological properties, in particular are activators of AMPK and which are therefore useful in the treatment of certain disorders that can be prevented or treated by activation of this receptor. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2.

SMALL-MOLECULE BOTULINUM TOXIN INHIBITORS

This disclosure relates to materials and methods for inhibiting Botulinum neurotoxin, and more particularly to materials and methods for inhibiting the zinc endopeptidase of Botulinum neurotoxin serotypes A, D and/or E (BoNTA, BoNTD and/or BoNTE).